301 related articles for article (PubMed ID: 25635988)
1. Treatment with icatibant in the management of drug induced angioedema.
Bertazzoni G; Bresciani E; Cipollone L; Fante E; Galandrini R
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):149-53. PubMed ID: 25635988
[TBL] [Abstract][Full Text] [Related]
2. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
Bartal C; Zeldetz V; Stavi V; Barski L
Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
[TBL] [Abstract][Full Text] [Related]
3. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.
Straka BT; Ramirez CE; Byrd JB; Stone E; Woodard-Grice A; Nian H; Yu C; Banerji A; Brown NJ
J Allergy Clin Immunol; 2017 Jul; 140(1):242-248.e2. PubMed ID: 27913306
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
Baş M; Greve J; Stelter K; Havel M; Strassen U; Rotter N; Veit J; Schossow B; Hapfelmeier A; Kehl V; Kojda G; Hoffmann TK
N Engl J Med; 2015 Jan; 372(5):418-25. PubMed ID: 25629740
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].
Muller Y; Harr T
Rev Med Suisse; 2016 Jan; 12(500):11-2. PubMed ID: 26946694
[TBL] [Abstract][Full Text] [Related]
6. Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.
Fok JS; Katelaris CH; Brown AF; Smith WB
Intern Med J; 2015 Aug; 45(8):821-7. PubMed ID: 25944565
[TBL] [Abstract][Full Text] [Related]
7. [Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor].
Fast S; Henningsen E; Bygum A
Ugeskr Laeger; 2011 Oct; 173(41):2574-5. PubMed ID: 21985837
[TBL] [Abstract][Full Text] [Related]
8. Treatment of ACEI-related angioedema with icatibant: a case series.
Bova M; Guilarte M; Sala-Cunill A; Borrelli P; Rizzelli GM; Zanichelli A
Intern Emerg Med; 2015 Apr; 10(3):345-50. PubMed ID: 25666515
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin B2 receptor antagonist off label use in short-term prophylaxis in hereditary angioedema.
Angeletti C; Angeletti PM; Mastrobuono F; Pilotti L; Ciccozzi A; Guetti C
Int J Immunopathol Pharmacol; 2014; 27(4):653-9. PubMed ID: 25572747
[TBL] [Abstract][Full Text] [Related]
10. Icatibant as a Potential Treatment of Life-Threatening Alteplase-Induced Angioedema.
Cheong E; Dodd L; Smith W; Kleinig T
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):e36-e37. PubMed ID: 29097062
[TBL] [Abstract][Full Text] [Related]
11. The Angiotensin-Converting-Enzyme-Induced Angioedema.
Bas M
Immunol Allergy Clin North Am; 2017 Feb; 37(1):183-200. PubMed ID: 27886906
[TBL] [Abstract][Full Text] [Related]
12. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.
Gallitelli M; Alzetta M
Am J Emerg Med; 2012 Oct; 30(8):1664.e1-2. PubMed ID: 22100478
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
Bas M; Greve J; Stelter K; Bier H; Stark T; Hoffmann TK; Kojda G
Ann Emerg Med; 2010 Sep; 56(3):278-82. PubMed ID: 20447725
[TBL] [Abstract][Full Text] [Related]
14. Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years.
Farkas H; Kőhalmi KV
Expert Rev Clin Immunol; 2018 Jun; 14(6):447-460. PubMed ID: 29757016
[TBL] [Abstract][Full Text] [Related]
15. Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema.
Sinert R; Levy P; Bernstein JA; Body R; Sivilotti MLA; Moellman J; Schranz J; Baptista J; Kimura A; Nothaft W;
J Allergy Clin Immunol Pract; 2017; 5(5):1402-1409.e3. PubMed ID: 28552382
[TBL] [Abstract][Full Text] [Related]
16. Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.
Charignon D; Späth P; Martin L; Drouet C
Expert Opin Pharmacother; 2012 Oct; 13(15):2233-47. PubMed ID: 22970904
[TBL] [Abstract][Full Text] [Related]
17. Two cases of severe angio-oedema and rationale for their response to icatibant.
Akinduro OO; Patel V; Thomas T; Ahmad FU
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26678695
[No Abstract] [Full Text] [Related]
18. MDMA-induced angioedema treated with icatibant.
Escalante FA; Del Baño F; Supervía A
Clin Toxicol (Phila); 2015; 53(10):1148-9. PubMed ID: 26479353
[No Abstract] [Full Text] [Related]
19. Icatibant Compared to Steroids and Antihistamines for ACE-Inhibitor-Induced Angioedema.
Botnaru T; Robert A; Mottillo S
CJEM; 2017 Mar; 19(2):159-162. PubMed ID: 27189625
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of ACE inhibitor-induced angioedema with icatibant, a bradykinin B2 receptor antagonist.
Pucar PA; O'Sullivan M; Goudie A; Marr T; Brusch A
Med J Aust; 2015 Jun; 202(11):596-7. PubMed ID: 26068694
[No Abstract] [Full Text] [Related]
[Next] [New Search]
